Maggie Chu

743 total citations
20 papers, 463 citations indexed

About

Maggie Chu is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maggie Chu has authored 20 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maggie Chu's work include Dialysis and Renal Disease Management (12 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Central Venous Catheters and Hemodialysis (4 papers). Maggie Chu is often cited by papers focused on Dialysis and Renal Disease Management (12 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Central Venous Catheters and Hemodialysis (4 papers). Maggie Chu collaborates with scholars based in Canada, United States and Sweden. Maggie Chu's co-authors include Joanne M. Bargman, Dimitrios G. Oreopoulos, Stephen I. Vas, Elias Thodis, Murali Krishnan, E. Vidgen, Manoj Singhal, Hemal Shah, Elias V. Balaskas and Robert Uldall and has published in prestigious journals such as Transplantation, Journal of Immunology Research and Peritoneal Dialysis International.

In The Last Decade

Maggie Chu

20 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maggie Chu Canada 12 307 158 136 63 58 20 463
Sing‐Leung Lui China 15 299 1.0× 149 0.9× 230 1.7× 80 1.3× 83 1.4× 32 652
Brett Cullis South Africa 11 583 1.9× 247 1.6× 204 1.5× 78 1.2× 54 0.9× 28 770
J. Álvarez-Grande Spain 11 120 0.4× 74 0.5× 122 0.9× 82 1.3× 89 1.5× 25 499
Chun Sang Li China 14 174 0.6× 112 0.7× 135 1.0× 89 1.4× 79 1.4× 26 576
Henk W. van Hamersvelt Netherlands 11 159 0.5× 40 0.3× 45 0.3× 24 0.4× 103 1.8× 28 404
Lynn A. Donaldson United States 11 299 1.0× 124 0.8× 173 1.3× 101 1.6× 30 0.5× 15 660
Robert Peel United Kingdom 9 133 0.4× 137 0.9× 63 0.5× 123 2.0× 47 0.8× 19 307
Scott Sibbel United States 12 181 0.6× 55 0.3× 53 0.4× 56 0.9× 36 0.6× 27 441
Vincent Allot France 7 323 1.1× 60 0.4× 80 0.6× 70 1.1× 50 0.9× 12 552
J.S. Tapson United Kingdom 14 222 0.7× 101 0.6× 111 0.8× 190 3.0× 45 0.8× 32 497

Countries citing papers authored by Maggie Chu

Since Specialization
Citations

This map shows the geographic impact of Maggie Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Chu more than expected).

Fields of papers citing papers by Maggie Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Chu. The network helps show where Maggie Chu may publish in the future.

Co-authorship network of co-authors of Maggie Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie Chu. A scholar is included among the top collaborators of Maggie Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie Chu. Maggie Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Shili, Maggie Chu, Joseph Kahwaji, et al.. (2022). Viral‐specific cytotoxic T‐cell responses in HLA‐sensitized kidney transplant patients maintained on everolimus and low‐dose tacrolimus. Transplant Infectious Disease. 24(2). e13805–e13805. 1 indexed citations
2.
Jordan, Stanley C., Maggie Chu, Ashley Vo, et al.. (2021). Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients. Transplantation. 106(1). e90–e91. 3 indexed citations
3.
Jordan, Stanley C., Noriko Ammerman, Mieko Toyoda, et al.. (2020). CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377). Transplantation. 104(S3). S67–S68. 4 indexed citations
4.
Ge, Shili, Maggie Chu, Jua Choi, et al.. (2019). Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro. Transplantation. 104(8). 1574–1579. 27 indexed citations
5.
Toyoda, Mieko, Shili Ge, James Mirocha, et al.. (2017). Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients. Journal of Immunology Research. 2017. 1–24. 25 indexed citations
6.
Sekercioglu, Nigar, Rosilene Motta Elias, Joseph Kim, et al.. (2013). Peritoneal dialysis outcomes in a modern cohort of overweight patients. International Urology and Nephrology. 46(1). 183–189. 6 indexed citations
7.
Dousdampanis, Periklis, et al.. (2010). Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center’s experience and review of the literature. International Urology and Nephrology. 43(1). 203–209. 15 indexed citations
8.
Dousdampanis, Periklis, et al.. (2010). Encapsulating peritoneal sclerosis: a single-center experience and review of the literature. International Urology and Nephrology. 43(2). 519–526. 29 indexed citations
9.
Cornelis, T., et al.. (2010). Discordant PD Catheter and Effluent Culture Results. The Limited Clinical Relevance of Culturing PD Catheters. Peritoneal Dialysis International. 31(2). 173–178. 2 indexed citations
10.
Dimković, Nada, et al.. (2009). Assisted peritoneal dialysis: what is it and who does it involve?. PubMed. 25. 165–70. 17 indexed citations
11.
Shah, Hemal, Maggie Chu, & Joanne M. Bargman. (2006). Perioperative Management of Peritoneal Dialysis Patients Undergoing Hernia Surgery without the use of Interim Hemodialysis. Peritoneal Dialysis International. 26(6). 684–687. 36 indexed citations
12.
Sunder, S., Hülya Taşkapan, Murali Krishnan, et al.. (2004). Chronic peritoneal dialysis in the tenth decade of life. International Urology and Nephrology. 36(4). 605–609. 12 indexed citations
13.
Shukla, Ashutosh M., et al.. (2004). Peritoneal dialysis in end-stage renal disease after liver transplantation.. PubMed. 20. 93–7. 5 indexed citations
14.
Cherney, David Z.I., et al.. (2004). Natural history and outcome of incarcerated abdominal hernias in peritoneal dialysis patients.. PubMed. 20. 86–9. 19 indexed citations
15.
Wang, Tao, Maggie Chu, Joanne M. Bargman, et al.. (2003). Differences in survival on peritoneal dialysis between oriental Asians and Caucasians: One center's experience. International Urology and Nephrology. 35(2). 267–274. 11 indexed citations
16.
Krishnan, Murali, Elias Thodis, E. Vidgen, et al.. (2002). Predictors of Outcome following Bacterial Peritonitis in Peritoneal Dialysis. Peritoneal Dialysis International. 22(5). 573–581. 127 indexed citations
17.
Jassal, Sarbjit V., et al.. (2001). Increased mortality of elderly female peritoneal dialysis patients with diabetes--a descriptive analysis.. PubMed. 17. 117–21. 5 indexed citations
18.
Thodis, Elias, Stephen I. Vas, Joanne M. Bargman, et al.. (1998). Nystatin Prophylaxis: Its Inability to Prevent Fungal Peritonitis in Patients on Continuous Ambulatory Peritoneal Dialysis. Peritoneal Dialysis International. 18(6). 583–589. 77 indexed citations
19.
Rao, Suchitra, et al.. (1998). The Futility of Pretransplant Coronary Bypass Grafting in Asymptomatic Patients on Peritoneal Dialysis. Peritoneal Dialysis International. 18(5). 485–488. 2 indexed citations
20.
Balaskas, Elias V., Maggie Chu, Robert Uldall, Aditya K. Gupta, & Dimitrios G. Oreopoulos. (1993). Pruritus in Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Patients. Peritoneal Dialysis International. 13(2_suppl). 527–532. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sing‐Leung Lui Breakdown of academic impact, for papers by Brett Cullis Breakdown of academic impact, for papers by J. Álvarez-Grande Breakdown of academic impact, for papers by Chun Sang Li Breakdown of academic impact, for papers by Henk W. van Hamersvelt Breakdown of academic impact, for papers by Lynn A. Donaldson Breakdown of academic impact, for papers by Robert Peel Breakdown of academic impact, for papers by Scott Sibbel Breakdown of academic impact, for papers by Vincent Allot Breakdown of academic impact, for papers by J.S. Tapson
Rankless by CCL
2026